Drug Trial Radar · NCT05456425
A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium
Last checked: Nov 19, 2026Latest source record: Sep 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
660
Actual
Start
Jun 30, 2022
Primary completion
Dec 31, 2026
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Cloudbreak Therapeutics, LLCIndustry
- Sponsor type
- Industry
- First posted
- Jul 13, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective is to evaluate the safety and efficacy of low dose and high dose CBT-001 eye drop dosed twice daily for 24 months compared to vehicle in reducing conjunctival hyperemia and preventing pterygium progression in eyes with pterygia.
Conditions
- Pterygium
Interventions
CBT-001Drug
CBT-001 eye drop
VehicleDrug
Formulation without drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- conjunctival hyperemiaTime frame: 3 month
- pterygium lengthTime frame: 12 month
Locations
44 sites in 5 countries. Site status is shown where the registry gives one.
Trinity Research Group
Dothan, Alabama
Horizon Eye Specialists & LASIK Center
Sun City, Arizona
West Coast Eye Institute
Bakersfield, California
Global Research Mangement
Glendale, California
Inland Eye Specialists
Hemet, California
Eye Research Foundation
Newport Beach, California
Shultz Chang Vision
Northridge, California
North Bay Eye Associates INC
Petaluma, California
Santa Barbara Eye Care
Santa Barbara, California
Advanced Research; LLC
Deerfield Beach, Florida
Bruce A. Segal, MD
Delray Beach, Florida
International Research Center
Tampa, Florida
The Eye Care Institute
Louisville, Kentucky
Center for Sight
Henderson, Nevada
Vance Thompson Vision
Sioux Falls, South Dakota
Baylor College of Medicine
Houston, Texas
DCT-Shah Research, LLC dba Discovery Clinical Trials
McAllen, Texas
Clinical Trials of Texas
San Antonio, Texas
R and R Eye Research
San Antonio, Texas
Emerson Clinical Research Institute, LLC
Falls Church, Virginia
The Centre for Eye Research Australia
East Melbourne, Melbourne, Australia
Eyeclinic Albury Wodonga
Albury, New South Wales, Australia
Sydney Eye Hospital
Sydney, New South Wales, Australia
Bendigo Eye Clinic
Bendigo, Victoria, Australia
Sunshine Eye Surgeons
St Albans, Victoria, Australia
Beijing Tongren Hospital; CMU
Beijing, China
West China Hospital of Sichuan University
Chengdu, China
Hainan Provincial Eye Hospital
Haikou, China
1st Affiliated Hospital of University of South China
Hengyang, China
The Second People's Hospital of Yunnan Province
Kunming, China
The First Affiliated Hospital of NC University
Nanchang, China
Eye Hospital of Shandong First Medical University
Qingdao, China
Eye Hospital of Wenzhou Medical University
Wenzhou, China
Union Hospital Tongji Medical College
Wuhan, China
Xiamen Eye Center of Xiamen University
Xiamen, China
Advanced Eye Centre PGIMER
Chandigarh, Chandigarh, India
Netralaya Super Specialty Eye Hospital
Ahmedabad, Gujarat, India
Narayana Nethralaya
Bangalore, Karnataka, India
L V Prasad Eye Institute
Bhubaneswar, Odisha, India
SP Medical College and AG of Hospitals
Bikaner, Rajasthan, India
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.